投资人会议.PDFVIP

投資人會議 2017年 11月 Disclaimer This presentation contains forward-looking statements. These forward looking statements are not based on historical facts but rather on management’s expectations regarding future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Statements in this Prospectus about our future plans and intentions, results, level of activity, performance, goals or achievements or other future events constitute forward looking statements. Wherever possible, words such as “anticipate”, “believe”, “expect”, “may”, “could”, “will”, “potential”, “intend”, “estimate”, “should”, “plan”, “predict” or the negative or other variations of statements reflect management’s current beliefs and assumptions and are based on information currently available to our management. Certain risk factors may cause our actual results, level of activity, performance or achievements to differ materially from those implied by forward looking statements. These factors should be considered carefully and prospective investors should not place undue reliance on the forward looking statements. Although the forward looking statements contained in this presentation are based upon what our management believes to be reasonable assumptions, we cannot assure investors that actual results will be consistent with these forward looking statements. These forward looking statements are made as of the date of this presentation, and we assume no obligation to update or revise them to reflect new events or circumstances. 2 Agenda •營運進度報告 • 產品組合及營收報告 • 策略及展望 3 營運進度報告 • 憂鬱症用藥Bupropion HCl ER Tablet (TWi-015